Health and Healthcare

Biogen : BIIB

All Biogen Articles

607 Articles

Chris Lange | Nov 27, 2017 at 10:05 AM EST

Alkermes Could Win Big With New Biogen Partnership

Alkermes saw its shares make a handy gain to start off the week, after the firm announced that it has…

Chris Lange | Nov 10, 2017 at 10:40 AM EST

Short Sellers Grow More Selective on Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech…

Lee Jackson | Nov 10, 2017 at 10:15 AM EST

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar…

Jon C. Ogg | Nov 9, 2017 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

The top analyst upgrades, downgrades and other research calls from Thursday include Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square,…

Chris Lange | Oct 25, 2017 at 10:40 AM EDT

Short Sellers Chase Biotechs Higher

The October 13 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Oct 25, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Apple, Biogen, Capital One, Chipotle, GM, 3M and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AMD, Apple, Biogen, Capital One, Chipotle Mexican Grill,…

Jon C. Ogg | Oct 23, 2017 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Equifax, Foot Locker, GE, NVIDIA, Rio Tinto, Roku and More

The top analyst upgrades, downgrades and other research calls from Monday include Biogen, Equifax, Foot Locker, General Electric, NVIDIA, Rio…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Jon C. Ogg | Oct 17, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix, UnitedHealth and Many More

The top analyst upgrades, downgrades and other research calls from Tuesday include Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix…

Chris Lange | Oct 11, 2017 at 11:35 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Sep 27, 2017 at 10:25 AM EDT

Short Sellers Hike Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest in all the selected…

Jon C. Ogg | Sep 26, 2017 at 12:10 PM EDT

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…

Jon C. Ogg | Sep 21, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

The top analyst upgrades, downgrades and other research calls from Thursday include AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron…

Jon C. Ogg | Sep 20, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson,…

Chris Lange | Sep 13, 2017 at 8:55 AM EDT

Short Sellers Hike Bets in Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest in most of the…

1 … 14 15 16 17 18 … 41

Biogen : BIIB

All Biogen Articles

Alkermes Could Win Big With New Biogen Partnership

Short Sellers Grow More Selective on Major Biotechs

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

Short Sellers Chase Biotechs Higher

Top Analyst Upgrades and Downgrades: AMD, Apple, Biogen, Capital One, Chipotle, GM, 3M and More

Top Analyst Upgrades and Downgrades: Biogen, Equifax, Foot Locker, GE, NVIDIA, Rio Tinto, Roku and More

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Top Analyst Upgrades and Downgrades: Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix, UnitedHealth and Many More

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Hike Bets in Major Biotechs

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Short Sellers Hike Bets in Major Biotechs

‘Your Spouse Has All Kinds of Benefits That Nobody Else Has’: Suze Orman to a 76-Year-Old Who Doubled Her Husband’s 401(k)

‘Horrible, Horrible, Horrible’: Dave Ramsey Shreds a Debt-Free Retiree’s Plan to Lease a New Car Every 3 Years

‘Who Sends a Bill to Their Kid for $4,000?’: Dave Ramsey on a Couple Blindsided by In-Law Wedding Debt

'Your Spouse Has All Kinds of Benefits That Nobody Else Has': Suze Orman to a 76-Year-Old Who Doubled Her Husband's 401(k)

'Horrible, Horrible, Horrible': Dave Ramsey Shreds a Debt-Free Retiree's Plan to Lease a New Car Every 3 Years

‘Your Spouse Has All Kinds of Benefits That Nobody Else Has’: Suze Orman to a 76-Year-Old Who Doubled Her Husband’s 401(k)

‘Horrible, Horrible, Horrible’: Dave Ramsey Shreds a Debt-Free Retiree’s Plan to Lease a New Car Every 3 Years

Biogen : BIIB

All Biogen Articles

Alkermes Could Win Big With New Biogen Partnership

Short Sellers Grow More Selective on Major Biotechs

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

Short Sellers Chase Biotechs Higher

Top Analyst Upgrades and Downgrades: AMD, Apple, Biogen, Capital One, Chipotle, GM, 3M and More

Top Analyst Upgrades and Downgrades: Biogen, Equifax, Foot Locker, GE, NVIDIA, Rio Tinto, Roku and More

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Top Analyst Upgrades and Downgrades: Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix, UnitedHealth and Many More

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Hike Bets in Major Biotechs

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Short Sellers Hike Bets in Major Biotechs

‘Your Spouse Has All Kinds of Benefits That Nobody Else Has’: Suze Orman to a 76-Year-Old Who Doubled Her Husband’s 401(k)

‘Horrible, Horrible, Horrible’: Dave Ramsey Shreds a Debt-Free Retiree’s Plan to Lease a New Car Every 3 Years

‘Who Sends a Bill to Their Kid for $4,000?’: Dave Ramsey on a Couple Blindsided by In-Law Wedding Debt

Featured Reads

'Your Spouse Has All Kinds of Benefits That Nobody Else Has': Suze Orman to a 76-Year-Old Who Doubled Her Husband's 401(k)

'Horrible, Horrible, Horrible': Dave Ramsey Shreds a Debt-Free Retiree's Plan to Lease a New Car Every 3 Years